ATE335745T1 - Verfahren zur herstellung von protease hemmenden zwischenprodukten - Google Patents

Verfahren zur herstellung von protease hemmenden zwischenprodukten

Info

Publication number
ATE335745T1
ATE335745T1 AT02761678T AT02761678T ATE335745T1 AT E335745 T1 ATE335745 T1 AT E335745T1 AT 02761678 T AT02761678 T AT 02761678T AT 02761678 T AT02761678 T AT 02761678T AT E335745 T1 ATE335745 T1 AT E335745T1
Authority
AT
Austria
Prior art keywords
intermediate products
producing protease
inhibiting intermediate
present
inhibiting
Prior art date
Application number
AT02761678T
Other languages
English (en)
Inventor
Brian Daniel Doan
Roman D Davis
Thomas Claiborne Lovelace
Box Po
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE335745T1 publication Critical patent/ATE335745T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Enzymes And Modification Thereof (AREA)
AT02761678T 2001-09-20 2002-09-16 Verfahren zur herstellung von protease hemmenden zwischenprodukten ATE335745T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32369201P 2001-09-20 2001-09-20

Publications (1)

Publication Number Publication Date
ATE335745T1 true ATE335745T1 (de) 2006-09-15

Family

ID=23260324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02761678T ATE335745T1 (de) 2001-09-20 2002-09-16 Verfahren zur herstellung von protease hemmenden zwischenprodukten

Country Status (8)

Country Link
US (1) US7145024B2 (de)
EP (1) EP1465897B1 (de)
JP (1) JP2005510467A (de)
AT (1) ATE335745T1 (de)
AU (1) AU2002326925A1 (de)
DE (1) DE60213874T2 (de)
ES (1) ES2265052T3 (de)
WO (1) WO2003024974A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2268427T3 (es) * 2002-06-27 2007-03-16 Smithkline Beecham Corporation Preparacion de estereoisomeros de (3alfa, 3alfa/beta, 6alfa/beta) hexahidrofuro(2,3-b)furan-3-ol.
EP1589018A4 (de) * 2002-12-27 2007-03-14 Sumitomo Chemical Co Herstellungsverfahren für hexahydrofurofuranol-derivate, zwischenprodukt davon und herstellungsverfahren dafür
US20060148865A1 (en) * 2003-06-27 2006-07-06 Martin Michael T Preparation of chemical compounds
RS51675B (sr) 2006-11-09 2011-10-31 Tibotec Pharmaceuticals Metode za dobivanje heksahidrofuro[2,3-b]furan-3-ola
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
PL2528923T3 (pl) 2010-01-28 2015-01-30 Mapi Pharma Ltd Sposób wytwarzania darunawiru i pochodnych darunawiru
WO2011156095A2 (en) 2010-06-10 2011-12-15 The Regents Of The University Of California Textile-based printable electrodes for electrochemical sensing
US8841467B2 (en) 2010-11-23 2014-09-23 Mylan Laboratories Limited Process for the preparation of (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-ol
KR101542549B1 (ko) 2011-09-02 2015-08-06 산디아 코포레이션 바이오센싱 및 약물 전달을 위한 마이크로니들 어레이
CN106977526A (zh) * 2017-05-25 2017-07-25 河南省商业科学研究所有限责任公司 一种3,4‑二甲基噻吩[2,3‑b]并噻吩的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026749A1 (en) * 1993-05-14 1994-11-24 Merck & Co., Inc. Hiv protease inhibitors
US5810766A (en) 1995-02-28 1998-09-22 Chiron Vision Corporation Infusion/aspiration apparatus with removable cassette

Also Published As

Publication number Publication date
ES2265052T3 (es) 2007-02-01
DE60213874T2 (de) 2007-10-18
DE60213874D1 (de) 2006-09-21
EP1465897B1 (de) 2006-08-09
AU2002326925A1 (en) 2003-04-01
JP2005510467A (ja) 2005-04-21
WO2003024974A3 (en) 2004-07-29
US20040204595A1 (en) 2004-10-14
US7145024B2 (en) 2006-12-05
WO2003024974A2 (en) 2003-03-27
EP1465897A2 (de) 2004-10-13

Similar Documents

Publication Publication Date Title
DE50312217D1 (de) Verfahren zur herstellung von 1-olefinen durch katalytische spaltung von 1-alkoxyalkanen
WO2004096818A3 (en) Method and compositions for identifying anti-hiv therapeutic compounds
DE60204322D1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
ATE125157T1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
ATE354648T1 (de) Verfahren zur herstellung eines virus inaktivierten thrombin präparates
ATE440078T1 (de) Verfahren zur herstellung von alkylaminen
ATE430160T1 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
DE60210298D1 (de) Verfahren zur herstellung von polynucleotivarianten
ATE472251T1 (de) Verfahren zur fruchtausdünnung
DE60213874D1 (de) Verfahren zur herstellung von protease hemmenden zwischenprodukten
TW200726479A (en) Method of inducing neutralizing antibodies to human immunodeficiency virus
ATE204851T1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
ATE344273T1 (de) Verfahren zur herstellung von 21-hydroxy-6,19- oxidoprogesteron (21oh-6op)
ATE404577T1 (de) Verfahren zur herstellung von eplerenon
DE60219927D1 (de) Verfahren zur herstellung von glycopeptid- phosphonat-derivaten
WO2001060838A3 (en) Aids ancestral viruses and vaccines
WO2003100036A3 (fr) Sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih.
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
WO2005001029A3 (en) Ancestral viruses and vaccines
ATE340788T1 (de) Herstellung von stereoisomeren von (3alpha, 3alpha/beta, 6alpha/beta)hexahydrofuro(2,3- böfuran-3-ol
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE50112449D1 (de) Verfahren zur herstellung von 3,3-diarylpropylaminen
DE60103560D1 (de) Prozess zur herstellung von paclitaxel
ATE386015T1 (de) Verfahren zur herstellung von alkyl-n-(3- dimethylamino)alkylcarbamaten
DE50103009D1 (de) Verfahren zur herstellung von 2-alkyl-3-chlorphenolen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties